Explore Victoria’s clinical trial capability and investigate how your organisation can benefit from working with Victoria.
Clinical trials are a critical aspect in innovation and generation of evidence-based medical interventions and the delivery of optimal treatments and high-quality healthcare. Victoria is recognised as an international leader in clinical trials, with one-third of Australian clinical trials activity taking place in Victoria.
Victoria is home to exceptionally high-quality research and facilities including 150 public and 161 private hospitals where clinical trials can be conducted. Victoria also has a highly efficient ethics and regulatory framework including a single ethical review and the Clinical Trials Notification Scheme – a global benchmark in best practice in reducing the regulatory burden on clinical trial sponsors.
Moreover, Victoria boasts one of the world’s most diverse populations allowing a diverse participant recruitment pool. Finally, the R&D Tax Incentive offered to both Australian and international-owned companies makes access to Australian R&D tax benefits for conducting clinical trials more efficient.
Join us to discover the breadth of Victoria’s expertise and hear first-hand from leaders in the field of clinical trials. Explore Victoria’s clinical trial capability and investigate how your organisation can benefit from working with Victoria.
About Dr. Megan Robertson
Dr Megan Robertson is an alumna of the University of Melbourne where she completed a Bachelor of Medicine, Bachelor of Surgery (MBBS). She is the current Director of Research at St Vincent’s Hospital, Melbourne, and works as a Senior Intensivist at Epworth HealthCare (Richmond and Freemasons).
Megan is on the boards of BioMedical Research Victoria, the Caroline Chisolm Centre for Health Ethics and FearLess (PTSD-ANZ), the Biodevices Advisory Board at the ARC Training Centre in Biodevices at Swinburne University, and the Tuckwell Scholarship Selection Panel at ANU.
Megan also works with national bodies including the Australian Commission on Safety and Quality in Healthcare, AusBioTech, and the National Health and Medical Research Council. Previously, she held positions as the Director of Professional Affairs, CICM, as the Executive Director of Research at Epworth HealthCare, and as the Co-Director of the Intensive Care Unit at Epworth Freemasons.
About Tam Nguyen
Tam Nguyen has had an illustrious career. He works as Deputy Director of research at St Vincent’s Hospital and holds appointments at several universities. He is an Associate Professor for Melbourne Medical School,
an Adjunct Associate Professor of Research at Monash Medical School and
an adjunct Associate Professor at RMIT College of Science for Engineering and Health.
Tam has over 22 years experience working in the healthcare, health and medical research and research management sector including tertiary teaching hospitals, medical research institutes and universities across Australia.
As Deputy Director of research at St Vincent’s Hospital Melbourne, Tam is responsible for research strategy, research development and innovation. He leads a dynamic team dedicated to providing strategic and innovative solutions to facilitate health and medical research. His team leads the sector initiative in building the Victorian Clinical Trials Gateway™ web portal supported by the Victorian government.
Why choose Melbourne, Victoria, Australia for Clinical Trials?
- Victoria is home to exceptionally high-quality research and facilities including 150 public and 161 private hospitals where clinical trials can be conducted.
- Victoria also has a highly efficient ethics and regulatory framework including a single ethical review and the Clinical Trials Notification Scheme – a global benchmark in best practice in reducing the regulatory burden on clinical trial sponsors.
- Victoria boasts one of the world’s most diverse populations allowing a diverse participant recruitment pool. Finally, the R&D Tax Incentive offered to both Australian and international-owned companies makes access to Australian R&D tax benefits for conducting clinical trials more efficient.